Yet, for far too many, this vital step is fraught with delays and inaccuracies, leading to devastating consequences that ...

Approved by the Medicines and Healthcare products Regulatory Agency (MHRA), the injectable will cut down on immunotherapy ...

You’re young. You’re healthy. We’re not worried about cancer.” Those words echoed in doctor’s offices 2,500 miles apart.

It was thought that Bohdan Suprun might have an infection or pneumonia, but when antibiotics didn't help him, he knew it was far more serious.

One grandmother experienced this firsthand when she received a terminal cancer diagnosis. Her wish was to let the illness run ...

A new research paper was published in Volume 16 of Oncotarget on June 17, 2025, titled "Molecular landscape of HER2-mutated ...

Now researchers are turning to an unexpected source for early PDAC detection: faecal samples. While analysing poo might seem ...

The Jack & Sheryl Morris Cancer Center has welcomed its first patients as New Jersey's only National Cancer ...

Cauthen has previously lashed out on social media at people who were close to him who he said did not approve of his choice ...

Elahere is indicated for ovarian neoplasms, which constituted the largest segment by clinical indication and accounted for 85.44% or $429.38 million of the market in 2024. This se ...

A breast cancer research study at Emory University is one of thousands paused nationwide after more than $180 million in grants were cut.

Matt Cross, a youth hockey coach and cancer survivor, has turned his personal battle into a mission to educate and inspire ...